High METTL1 expression correlates with adverse prognosis in IPF patients, allowing for the classification of IPF into two molecular subtypes based on the expressions of the m7G regulatory genes (METTL1 and RNMT). Here, METTL1 is linked to idiopathic pulmonary fibrosis.